Skip to main content
PMC home page
Gut logoLink to Gut
. 1996;38(Suppl 2):S2–S4. doi: 10.1136/gut.38.suppl_2.s2

Hepatitis B in the Middle East: aspects of epidemiology and liver disease after infection.

A U Toukan 1
PMCID: PMC1398035  PMID: 8786048

Abstract

Postnatal horizontal transmission of hepatitis B virus (HBV) in early childhood seems to be the predominant method by which high hepatitis B carrier rates in the Middle East are maintained. The prevalence of hepatitis B surface antigen (HBsAg) positive status among siblings of HBV carriers is similar during childhood and adulthood, suggesting that childhood intrafamilial transmission patterns persist into adult life. There is a tendency for asymptomatic HBV carriers to have higher alanine aminotransferase (ALT) values, a feature that also tends to cluster in families. Infection in the first five years of life contributes most to the case load of chronic liver disease and thus to mortality from HBV. Mass hepatitis B immunisation programmes have been started, and while they may eventually reduce the HBV carrier state and liver disease loads significantly, prospects for total eradication of HBV in the near future are not good.

Full text

PDF
S2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bar-Shany S., Green M. S., Slepon R., Gilon E. Ethnic differences in the prevalence of hepatitis B surface antigen among Israeli blood donors: changes between 1972 and 1988. Int J Epidemiol. 1991 Mar;20(1):271–275. doi: 10.1093/ije/20.1.271. [DOI] [PubMed] [Google Scholar]
  2. Beasley R. P., Hwang L. Y., Lin C. C., Chien C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981 Nov 21;2(8256):1129–1133. doi: 10.1016/s0140-6736(81)90585-7. [DOI] [PubMed] [Google Scholar]
  3. Carman W. F., Jacyna M. R., Hadziyannis S., Karayiannis P., McGarvey M. J., Makris A., Thomas H. C. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989 Sep 9;2(8663):588–591. doi: 10.1016/s0140-6736(89)90713-7. [DOI] [PubMed] [Google Scholar]
  4. McMahon B. J., Alward W. L., Hall D. B., Heyward W. L., Bender T. R., Francis D. P., Maynard J. E. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985 Apr;151(4):599–603. doi: 10.1093/infdis/151.4.599. [DOI] [PubMed] [Google Scholar]
  5. Nashef L., Thalji A. Hepatitis B serology among the Palestinian population. Ann Trop Paediatr. 1992;12(3):321–325. doi: 10.1080/02724936.1992.11747592. [DOI] [PubMed] [Google Scholar]
  6. Obayashi A., Okochi K., Mayumi M. Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer. Gastroenterology. 1972 Apr;62(4):618–625. [PubMed] [Google Scholar]
  7. Skinhoj P., Al-Kassab S. Letter: Hepatitis-B antigen in Iraq. Lancet. 1973 Dec 1;2(7840):1269–1269. doi: 10.1016/s0140-6736(73)91013-1. [DOI] [PubMed] [Google Scholar]
  8. Szmuness W., Prince A. M., Hirsch R. L., Brotman B. Familial clustering of hepatitis B infection. N Engl J Med. 1973 Nov 29;289(22):1162–1166. doi: 10.1056/NEJM197311292892203. [DOI] [PubMed] [Google Scholar]
  9. Thursz M. R., Kwiatkowski D., Allsopp C. E., Greenwood B. M., Thomas H. C., Hill A. V. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med. 1995 Apr 20;332(16):1065–1069. doi: 10.1056/NEJM199504203321604. [DOI] [PubMed] [Google Scholar]
  10. Toukan A. U. Hepatitis B virus infection in urban residents of Jordan with particular reference to socioeconomic factors. Trop Gastroenterol. 1987 Jul-Sep;8(3):161–166. [PubMed] [Google Scholar]
  11. Toukan A. U., Sharaiha Z. K., Abu-el-Rub O. A., Hmoud M. K., Dahbour S. S., Abu-Hassan H., Yacoub S. M., Hadler S. C., Margolis H. S., Coleman P. J. The epidemiology of hepatitis B virus among family members in the Middle East. Am J Epidemiol. 1990 Aug;132(2):220–232. doi: 10.1093/oxfordjournals.aje.a115651. [DOI] [PubMed] [Google Scholar]
  12. al-Faleh F. Z., Ayoola E. A., Arif M., Ramia S., al-Rashed R., al-Jeffry M., al-Mofarreh M., al-Karawi M., al-Shabrawy M. Seroepidemiology of hepatitis B virus infection in Saudi Arabian children: a baseline survey for mass vaccination against hepatitis B. J Infect. 1992 Mar;24(2):197–206. doi: 10.1016/0163-4453(92)93006-c. [DOI] [PubMed] [Google Scholar]
  13. el Guneid A. M., Gunaid A. A., O'Neill A. M., Zureikat N. I., Coleman J. C., Murray-Lyon I. M. Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease. J Med Virol. 1993 Aug;40(4):330–333. doi: 10.1002/jmv.1890400413. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES